Home/Filings/4/0000899140-05-000711
4//SEC Filing

EON LABS INC 4

Accession 0000899140-05-000711

CIK 0001168061operating

Filed

Jul 26, 8:00 PM ET

Accepted

Jul 27, 4:31 PM ET

Size

18.4 KB

Accession

0000899140-05-000711

Insider Transaction Report

Form 4
Period: 2005-07-26
SHARGEL DR LEON
V.P., Biopharmaceutics
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2005-07-2612,0000 total
    Exercise: $17.50Exp: 2013-09-08Common Stock (12,000 underlying)
  • Exercise/Conversion

    Common Stock

    2005-07-26$31.00/sh30,000$930,0000 total
  • Exercise/Conversion

    Common Stock

    2005-07-26$28.75/sh+4,000$115,0000 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2005-07-264,0000 total
    Exercise: $28.75Exp: 2015-02-16Common Stock (4,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2005-07-2610,0000 total
    Exercise: $9.13Exp: 2012-07-03Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2005-07-26$17.50/sh+12,000$210,0600 total
  • Exercise/Conversion

    Common Stock

    2005-07-26$9.13/sh+10,000$91,2500 total
Footnotes (1)
  • [F1]Options become exercisable on effective date of the merger of Zodnas Acquisition Corp. with and into Eon Labs, Inc.

Issuer

EON LABS INC

CIK 0001168061

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001168061

Filing Metadata

Form type
4
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 4:31 PM ET
Size
18.4 KB